inactivated influenza vaccine Search Results


vaccine strains of h1n1 influenza viruses a/mc/45/2015  (Adimmune Inc)
90
Adimmune Inc vaccine strains of h1n1 influenza viruses a/mc/45/2015
Vaccine Strains Of H1n1 Influenza Viruses A/Mc/45/2015, supplied by Adimmune Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+influenza+vaccine/quadrivalent+inactivated+influenza+vaccine/pmc06410868-273-1-16
Average 90 stars, based on 1 article reviews
vaccine strains of h1n1 influenza viruses a/mc/45/2015 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
seasonal human trivalent influenza vaccine fluvax™ 2010  (CSL Limited)
90
CSL Limited seasonal human trivalent influenza vaccine fluvax™ 2010
Seasonal Human Trivalent Influenza Vaccine Fluvax™ 2010, supplied by CSL Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+influenza+vaccine/inactivated+influenza+vaccine/pmc04216316-111-0-10
Average 90 stars, based on 1 article reviews
seasonal human trivalent influenza vaccine fluvax™ 2010 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
lt-adjuvanted inactivated influenza vaccine  (Berna Biotech Ltd)
90
Berna Biotech Ltd lt-adjuvanted inactivated influenza vaccine
Lt Adjuvanted Inactivated Influenza Vaccine, supplied by Berna Biotech Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+influenza+vaccine/lt+adjuvanted+inactivated+influenza+vaccine/pmc06060342-56-11-18
Average 90 stars, based on 1 article reviews
lt-adjuvanted inactivated influenza vaccine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
inactivated influenza vaccine tiv  (Adimmune Inc)
90
Adimmune Inc inactivated influenza vaccine tiv
Inactivated Influenza Vaccine Tiv, supplied by Adimmune Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+influenza+vaccine/inactivated+influenza+vaccine+tiv/pmc06954487-65-8-15
Average 90 stars, based on 1 article reviews
inactivated influenza vaccine tiv - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
trivalent inactivated split-virus influenza vaccine  (Ayerst Laboratories)
90
Ayerst Laboratories trivalent inactivated split-virus influenza vaccine
Trivalent Inactivated Split Virus Influenza Vaccine, supplied by Ayerst Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+influenza+vaccine/trivalent+inactivated+split+virus+influenza+vaccine/10__1002_slash_14651858__cd004879__pub4-1587-8-13
Average 90 stars, based on 1 article reviews
trivalent inactivated split-virus influenza vaccine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
influenza vaccine  (Sinovac BioTech)
90
Sinovac BioTech influenza vaccine
Influenza Vaccine, supplied by Sinovac BioTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+influenza+vaccine/h1n1+influenza+a+vaccine++split+virion++inactivated+/pmc07269036-187-9-2
Average 90 stars, based on 1 article reviews
influenza vaccine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
inactivated influenza vaccine  (Denka Co Ltd)
90
Denka Co Ltd inactivated influenza vaccine
Inactivated Influenza Vaccine, supplied by Denka Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+influenza+vaccine/inactivated+influenza+vaccine/pm40209094-40-10-13
Average 90 stars, based on 1 article reviews
inactivated influenza vaccine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
trivalent inactivated split influenza vaccine flulaval  (ID Biomedical Corporation)
90
ID Biomedical Corporation trivalent inactivated split influenza vaccine flulaval
Comparison 1 <t>Inactivated</t> parenteral influenza vaccine versus placebo or 'do nothing', Outcome 7 Working days lost.
Trivalent Inactivated Split Influenza Vaccine Flulaval, supplied by ID Biomedical Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+influenza+vaccine/trivalent+inactivated+split+influenza+vaccine+flulaval/pmc06491184-4834-16-32
Average 90 stars, based on 1 article reviews
trivalent inactivated split influenza vaccine flulaval - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
inactivated influenza vaccine pharmajet stratis  (PharmaJet Inc)
90
PharmaJet Inc inactivated influenza vaccine pharmajet stratis
Comparison 1 <t>Inactivated</t> parenteral influenza vaccine versus placebo or 'do nothing', Outcome 7 Working days lost.
Inactivated Influenza Vaccine Pharmajet Stratis, supplied by PharmaJet Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+influenza+vaccine/inactivated+influenza+vaccine+pharmajet+stratis/pmc09033795-54-15-14
Average 90 stars, based on 1 article reviews
inactivated influenza vaccine pharmajet stratis - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
inactivated influenza vaccines  (MedImmune llc)
90
MedImmune llc inactivated influenza vaccines
Comparison 1 <t>Inactivated</t> parenteral influenza vaccine versus placebo or 'do nothing', Outcome 7 Working days lost.
Inactivated Influenza Vaccines, supplied by MedImmune llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+influenza+vaccine/inactivated+influenza+vaccine/pm29425074-8-3-27
Average 90 stars, based on 1 article reviews
inactivated influenza vaccines - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
inactivated ndv (la sota) and subtype h9 avian influenza (strain f) vaccine  (Qingdao Yebio Bioengineering Co Ltd)
90
Qingdao Yebio Bioengineering Co Ltd inactivated ndv (la sota) and subtype h9 avian influenza (strain f) vaccine
Detection of interaction between selected VHH and <t>NDV</t> virion by ELISA. Microplates were coated with NDV <t>La</t> <t>Sota</t> virion (TCID 50 10 -8.17 /0.1 mL, 1:20 dilution). The 7 selected VHH (200 μg/mL) were diluted at different concentrations, and anti-NDV positive serum (Positive control), negative serum (Negative control 1) and 6 × His SUMO tag (Negative control 2) were used as positive and negative control. The value of absorbance at 450 nm indicate the reactivity between VHH and NDV. And the data represents the average of 3 wells
Inactivated Ndv (La Sota) And Subtype H9 Avian Influenza (Strain F) Vaccine, supplied by Qingdao Yebio Bioengineering Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+influenza+vaccine/inactivated+ndv++la+sota++and+subtype+h9+avian+influenza++strain+f++vaccine/pmc04769559-60-12-23
Average 90 stars, based on 1 article reviews
inactivated ndv (la sota) and subtype h9 avian influenza (strain f) vaccine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
trivalent inactivated vaccine against porcine influenza  (IDT Biologika)
90
IDT Biologika trivalent inactivated vaccine against porcine influenza
Detection of interaction between selected VHH and <t>NDV</t> virion by ELISA. Microplates were coated with NDV <t>La</t> <t>Sota</t> virion (TCID 50 10 -8.17 /0.1 mL, 1:20 dilution). The 7 selected VHH (200 μg/mL) were diluted at different concentrations, and anti-NDV positive serum (Positive control), negative serum (Negative control 1) and 6 × His SUMO tag (Negative control 2) were used as positive and negative control. The value of absorbance at 450 nm indicate the reactivity between VHH and NDV. And the data represents the average of 3 wells
Trivalent Inactivated Vaccine Against Porcine Influenza, supplied by IDT Biologika, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inactivated+influenza+vaccine/trivalent+inactivated+vaccine+against+porcine+influenza/10__1186_slash_1753___6561___5___s8___p128-6-12-18
Average 90 stars, based on 1 article reviews
trivalent inactivated vaccine against porcine influenza - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 7 Working days lost.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 7 Working days lost.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 1 Influenza.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 1 Influenza.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 2 Influenza‐like illness.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 2 Influenza‐like illness.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 8 Hospitalisations.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 8 Hospitalisations.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 11 Systemic harms.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 11 Systemic harms.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 3 Physician visits.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 3 Physician visits.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 4 Days ill.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 4 Days ill.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 5 Times any drugs were prescribed.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 5 Times any drugs were prescribed.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 6 Times antibiotic was prescribed.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 6 Times antibiotic was prescribed.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 4 Inactivated parenteral influenza vaccine versus placebo or 'do nothing' administered during pregnancy, Outcome 1 Influenza in mothers.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 4 Inactivated parenteral influenza vaccine versus placebo or 'do nothing' administered during pregnancy, Outcome 1 Influenza in mothers.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 4 Inactivated parenteral influenza vaccine versus placebo or 'do nothing' administered during pregnancy, Outcome 3 Influenza in newborn.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 4 Inactivated parenteral influenza vaccine versus placebo or 'do nothing' administered during pregnancy, Outcome 3 Influenza in newborn.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 4 Inactivated parenteral influenza vaccine versus placebo or 'do nothing' administered during pregnancy, Outcome 2 Influenza‐like illness in mothers.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 4 Inactivated parenteral influenza vaccine versus placebo or 'do nothing' administered during pregnancy, Outcome 2 Influenza‐like illness in mothers.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 4 Inactivated parenteral influenza vaccine versus placebo or 'do nothing' administered during pregnancy, Outcome 4 Influenza‐like illness in newborn.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 4 Inactivated parenteral influenza vaccine versus placebo or 'do nothing' administered during pregnancy, Outcome 4 Influenza‐like illness in newborn.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 5 Inactivated parenteral influenza vaccine versus placebo ‐ cohort studies, Outcome 6 Seasonal vaccine containing H1N1.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 5 Inactivated parenteral influenza vaccine versus placebo ‐ cohort studies, Outcome 6 Seasonal vaccine containing H1N1.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 13 1968 to 1969 pandemic: inactivated polyvalent parenteral influenza vaccine versus placebo, Outcome 1 Influenza‐like illness.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 13 1968 to 1969 pandemic: inactivated polyvalent parenteral influenza vaccine versus placebo, Outcome 1 Influenza‐like illness.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 13 1968 to 1969 pandemic: inactivated polyvalent parenteral influenza vaccine versus placebo, Outcome 2 Influenza.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 13 1968 to 1969 pandemic: inactivated polyvalent parenteral influenza vaccine versus placebo, Outcome 2 Influenza.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 14 1968 to 1969 pandemic: inactivated monovalent parenteral influenza vaccine versus placebo, Outcome 1 Influenza‐like illness.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 14 1968 to 1969 pandemic: inactivated monovalent parenteral influenza vaccine versus placebo, Outcome 1 Influenza‐like illness.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 14 1968 to 1969 pandemic: inactivated monovalent parenteral influenza vaccine versus placebo, Outcome 2 Influenza.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 14 1968 to 1969 pandemic: inactivated monovalent parenteral influenza vaccine versus placebo, Outcome 2 Influenza.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 14 1968 to 1969 pandemic: inactivated monovalent parenteral influenza vaccine versus placebo, Outcome 3 Hospitalisations.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 14 1968 to 1969 pandemic: inactivated monovalent parenteral influenza vaccine versus placebo, Outcome 3 Hospitalisations.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 14 1968 to 1969 pandemic: inactivated monovalent parenteral influenza vaccine versus placebo, Outcome 5 Working days lost.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 14 1968 to 1969 pandemic: inactivated monovalent parenteral influenza vaccine versus placebo, Outcome 5 Working days lost.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 14 1968 to 1969 pandemic: inactivated monovalent parenteral influenza vaccine versus placebo, Outcome 6 Days ill.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 14 1968 to 1969 pandemic: inactivated monovalent parenteral influenza vaccine versus placebo, Outcome 6 Days ill.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 14 1968 to 1969 pandemic: inactivated monovalent parenteral influenza vaccine versus placebo, Outcome 4 Pneumonia.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 14 1968 to 1969 pandemic: inactivated monovalent parenteral influenza vaccine versus placebo, Outcome 4 Pneumonia.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 3 Inactivated aerosol influenza vaccine versus placebo or 'do nothing', Outcome 1 Influenza.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 3 Inactivated aerosol influenza vaccine versus placebo or 'do nothing', Outcome 1 Influenza.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison, Aerosol

Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 9 Clinical cases (clinically defined without clear definition).

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 9 Clinical cases (clinically defined without clear definition).

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 10 Local harms.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 1 Inactivated parenteral influenza vaccine versus placebo or 'do nothing', Outcome 10 Local harms.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 3 Inactivated aerosol influenza vaccine versus placebo or 'do nothing', Outcome 2 Local harms.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 3 Inactivated aerosol influenza vaccine versus placebo or 'do nothing', Outcome 2 Local harms.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison, Aerosol

Comparison 3 Inactivated aerosol influenza vaccine versus placebo or 'do nothing', Outcome 3 Systemic harms.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 3 Inactivated aerosol influenza vaccine versus placebo or 'do nothing', Outcome 3 Systemic harms.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison, Aerosol

Comparison 5 Inactivated parenteral influenza vaccine versus placebo ‐ cohort studies, Outcome 1 Seasonal inactivated vaccine effectiveness in mothers ‐ pregnant women.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 5 Inactivated parenteral influenza vaccine versus placebo ‐ cohort studies, Outcome 1 Seasonal inactivated vaccine effectiveness in mothers ‐ pregnant women.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 5 Inactivated parenteral influenza vaccine versus placebo ‐ cohort studies, Outcome 2 Seasonal inactivated vaccine effectiveness in newborns ‐ pregnant women.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 5 Inactivated parenteral influenza vaccine versus placebo ‐ cohort studies, Outcome 2 Seasonal inactivated vaccine effectiveness in newborns ‐ pregnant women.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 5 Inactivated parenteral influenza vaccine versus placebo ‐ cohort studies, Outcome 3 Seasonal inactivated vaccine effectiveness in newborns ‐ pregnant women.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 5 Inactivated parenteral influenza vaccine versus placebo ‐ cohort studies, Outcome 3 Seasonal inactivated vaccine effectiveness in newborns ‐ pregnant women.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 5 Inactivated parenteral influenza vaccine versus placebo ‐ cohort studies, Outcome 4 H1N1 vaccine ‐ safety ‐ pregnancy‐related outcomes ‐ pregnant women.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 5 Inactivated parenteral influenza vaccine versus placebo ‐ cohort studies, Outcome 4 H1N1 vaccine ‐ safety ‐ pregnancy‐related outcomes ‐ pregnant women.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 5 Inactivated parenteral influenza vaccine versus placebo ‐ cohort studies, Outcome 5 Seasonal vaccine ‐ safety ‐ pregnancy‐related outcomes ‐ pregnant women.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 5 Inactivated parenteral influenza vaccine versus placebo ‐ cohort studies, Outcome 5 Seasonal vaccine ‐ safety ‐ pregnancy‐related outcomes ‐ pregnant women.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison

Comparison 6 Inactivated parenteral influenza vaccine versus placebo ‐ case‐control studies, Outcome 1 Effectiveness in newborns ‐ pregnant women (adjusted data).

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 6 Inactivated parenteral influenza vaccine versus placebo ‐ case‐control studies, Outcome 1 Effectiveness in newborns ‐ pregnant women (adjusted data).

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison, Control

Comparison 6 Inactivated parenteral influenza vaccine versus placebo ‐ case‐control studies, Outcome 2 Seasonal vaccine safety ‐ pregnancy‐related outcomes (adjusted data).

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 6 Inactivated parenteral influenza vaccine versus placebo ‐ case‐control studies, Outcome 2 Seasonal vaccine safety ‐ pregnancy‐related outcomes (adjusted data).

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison, Control

Comparison 16 1968 to 1969 pandemic: inactivated monovalent aerosol influenza vaccine versus placebo, Outcome 1 Influenza‐like illness.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: Comparison 16 1968 to 1969 pandemic: inactivated monovalent aerosol influenza vaccine versus placebo, Outcome 1 Influenza‐like illness.

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Comparison, Aerosol

1968 to 1969 pandemic: inactivated polyvalent aerosol influenza vaccine versus placebo

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: 1968 to 1969 pandemic: inactivated polyvalent aerosol influenza vaccine versus placebo

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Aerosol

1968 to 1969 pandemic: inactivated monovalent aerosol influenza vaccine versus placebo

Journal: The Cochrane Database of Systematic Reviews

Article Title: Vaccines for preventing influenza in healthy adults

doi: 10.1002/14651858.CD001269.pub6

Figure Lengend Snippet: 1968 to 1969 pandemic: inactivated monovalent aerosol influenza vaccine versus placebo

Article Snippet: Interventions Recruited participants were randomised at the beginning of each season to receive 1 dose of trivalent inactivated split influenza vaccine (FluLaval, a trademark of the GlaxoSmithKline group of companies; manufactured by ID Biomedical Corporation of Quebec, Canada) or saline placebo injection.

Techniques: Aerosol

Detection of interaction between selected VHH and NDV virion by ELISA. Microplates were coated with NDV La Sota virion (TCID 50 10 -8.17 /0.1 mL, 1:20 dilution). The 7 selected VHH (200 μg/mL) were diluted at different concentrations, and anti-NDV positive serum (Positive control), negative serum (Negative control 1) and 6 × His SUMO tag (Negative control 2) were used as positive and negative control. The value of absorbance at 450 nm indicate the reactivity between VHH and NDV. And the data represents the average of 3 wells

Journal: BMC Veterinary Research

Article Title: Construction of a camelid VHH yeast two-hybrid library and the selection of VHH against haemagglutinin-neuraminidase protein of the Newcastle disease virus

doi: 10.1186/s12917-016-0664-1

Figure Lengend Snippet: Detection of interaction between selected VHH and NDV virion by ELISA. Microplates were coated with NDV La Sota virion (TCID 50 10 -8.17 /0.1 mL, 1:20 dilution). The 7 selected VHH (200 μg/mL) were diluted at different concentrations, and anti-NDV positive serum (Positive control), negative serum (Negative control 1) and 6 × His SUMO tag (Negative control 2) were used as positive and negative control. The value of absorbance at 450 nm indicate the reactivity between VHH and NDV. And the data represents the average of 3 wells

Article Snippet: A six-month-old female C. bactrianus was immunized with a combination of inactivated NDV (La Sota) and subtype H9 avian influenza (Strain F) vaccine (Qingdao Yebio Bioengineering Co., Ltd, China) five times at two-weeks intervals.

Techniques: Enzyme-linked Immunosorbent Assay, Positive Control, Negative Control